Washington, D.C.– Neil Bradley, Executive Vice President and Chief Policy Officer at the U.S. Chamber of Commerce, today issued the following statement responding to the Centers for Medicare & Medicaid Services submitting price offers as part of the Medicare drug price negotiations:
"You can’t call it a negotiation when the federal government has the ability to force you to accept their price or face an excise tax that can total 1900% of all your sales. But the real costs will be paid by American patients. In fact, new research projects upwards of 44% fewer new medical product launches in the United States due to the government’s price control scheme.
“That is why the U.S. Chamber has sued the Department of Health and Human Services to safeguard American patients and protect the development of lifesaving breakthroughs that could one day benefit us all."